Biotech startup NewLimit has successfully closed a $435 million funding round following its announcement of a pioneering prototype drug that reverses liver cell aging. This breakthrough promises to advance the field of longevity medicine significantly.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More